ALT5 Sigma Corp. (ALTS)
1.58
-0.06
(-3.66%)
USD |
NASDAQ |
Dec 04, 16:00
1.58
0.00 (0.00%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 197.42M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -42.96% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.106 |
| Price to Book Value | 22.73 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.76 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 97.69% |
Profile
| ALT5 Sigma Corp. is a multidisciplinary organization with a focus on healthcare and fintech. The firm provides blockchain-powered technologies to enable a migration to a new global financial paradigm for the trading, clearing, settlement, payment, and custodianship of digital instruments. It operates through the following segments: Biotechnology and Corporate and Other. The Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Corporate and Other segment consists of certain corporate general and administrative costs. Its platforms: ALT5 Pay and ALT5 Prime. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV. |
| URL | http://www.alt5sigma.com |
| Investor Relations URL | https://ir.alt5sigma.com/ |
| HQ State/Province | Nevada |
| Sector | Financials |
| Industry | Capital Markets |
| Next Earnings Release | Dec. 08, 2025 (est.) |
| Last Earnings Release | Aug. 12, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| ALT5 Sigma Corp. is a multidisciplinary organization with a focus on healthcare and fintech. The firm provides blockchain-powered technologies to enable a migration to a new global financial paradigm for the trading, clearing, settlement, payment, and custodianship of digital instruments. It operates through the following segments: Biotechnology and Corporate and Other. The Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Corporate and Other segment consists of certain corporate general and administrative costs. Its platforms: ALT5 Pay and ALT5 Prime. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV. |
| URL | http://www.alt5sigma.com |
| Investor Relations URL | https://ir.alt5sigma.com/ |
| HQ State/Province | Nevada |
| Sector | Financials |
| Industry | Capital Markets |
| Next Earnings Release | Dec. 08, 2025 (est.) |
| Last Earnings Release | Aug. 12, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |